NYSE:STEMedical Equipment
How Investors May Respond To STERIS (STE) Record FY26 Results And US$1 Billion Buyback Plan
Earlier this week, STERIS plc reported its fourth-quarter and fiscal 2026 results, with full-year sales of US$5,935.9 million and net income of US$782.3 million, alongside new fiscal 2027 guidance calling for 7%–8% reported revenue growth and a fresh US$1.00 billion share repurchase authorization.
Management paired record annual revenue and earnings per share with plans for substantial buybacks and elevated capital spending, signaling confidence in the durability of demand for its infection...